Document:

Offer Letter Agreement

 EXHIBIT 10.18 
 [ZELTIQ AESTHETICS LOGO] 
 March 3, 2008 

 
 Re: EMPLOYEE OFFER
LETTER 
 Dear Dave: 
 ZELTIQ AESTHETICS, INC. (the “Company”) is pleased to offer you the position of Director, U.S. Sales, reporting to Edward Ebbers, VP of
Marketing and Sales. You will perform duties customarily associated with your position and such other duties as may be assigned by the VP of Marketing and Sales, the Chief Executive Officer of the Company, or his or her designate. You will be based
in your remote office in Southern California, but may be required to maintain up to 10 business days per month in Pleasanton, CA, or other such location to which the Company headquarters may relocate. By signing this letter agreement, you represent
and warrant to the Company that you are under no contractual commitments inconsistent with your obligations to the Company. 

1. COMPENSATION. 
  

	 	(a)	Pre-Commercial Launch 

Base Salary; You will be paid a base salary at the annual rate of $150,000, payable in semi-monthly installments or
otherwise in accordance with the Company’s standard payroll practices for salaried employees (“Base Salary”), The Base Salary may be adjusted pursuant to the Company’s employee compensation policies in effect from time to time.

 Bonus. Prior to the Company’s commercial launch, and in addition to your Base Salary, you will be eligible
to receive a bonus payable in quarterly increments (“Incremental Bonus”). Receipt of the Incremental Bonus will be based upon your satisfaction of pre-commercial sale objectives related to alpha/beta implementation and identified sales
force programs to be completed prior to commercial launch. Meeting these objectives, as reasonably judged solely by management, is pegged to a quarterly “met goals” bonus increment not to exceed $12,510 per quarter (which is the equivalent
to $50,040 per annum) for meeting goals, with an additional bonus available for exceeding quarterly goals, also as reasonably judged by management. Your eligibility for the Incremental Bonus will cease immediately upon the Company’s commercial
launch, when you will become eligible to earn commissions pursuant to a commission plan approved by Company management. 

Commission Draw. Prior to the Company’s commercial launch, and in addition to your Base Salary and potential
Incremental Bonus, you will be eligible to receive a draw against future commissions equal to $4,170 per month (“Draw”). Your eligibility for monthly Draw payments will cease immediately upon the Company’s commercial launch, when you
will become eligible to earn commissions pursuant to a commission plan approved by Company management. Your accrued Draw will be reconciled with commissions earned in accordance with the Draw Reconciliation Plan set forth in the attached Appendix
A, which is incorporated by reference herein. 
 Zeltiq Aesthetics    4698 Willow
Road    Pleasanton, CA    94588 
 Tel 925-474-2500    fax
925-474-7599    www.zeltiq.com 

  
 1 

	 	(b)	Post-Commercial Launch 

Base Salary. Following the Company’s commercial launch, you will continue to receive the Base Salary discussed above,
subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time. 

Commissions. Following the Company’s commercial launch, and in addition to your Base Salary, you will be eligible to
earn commissions pursuant to a commission plan approved by Company management. 
  

	 	(c)	Stock Options. 

Company’s management will recommend to the Company’s Board of Directors that you be granted an option (the “Stock
Option”) to purchase 100,000 shares of the Company’s Common Stock. The exercise price per share will be equal to the fair market value per share on the date the option is granted or on your first day of employment, whichever is later. The
Stock Option shall vest over four (4) years with one-fourth (1/4) of the options vesting at the end of twelve (12) months, and the remainder vesting monthly at a rate of 1/48th of the total number per month thereafter until all shares
are vested. The Stock Option shall be an incentive stock option to the extent permitted by applicable law. The Stock Option will be subject to the terms and conditions applicable to options granted under the Company’s 2005 Equity Incentive
Plan), and as described in that plan and the applicable stock option agreement. 
 2.
BENEFITS. You shall be entitled to the Company’s basic employment benefits available to all similarly-situated Company employees, as the same currently exist or may exist in the future. You acknowledge that
participation in Company benefit programs may require payroll deductions and/or direct contributions by you. 
 3.
EMPLOYMENT TERMS. Your employment relationship with the Company will be governed by the general employment policies and practices of the Company. You will be required as a condition of employment
with the Company, to (i) acknowledge your receipt and understanding, sign and abide by the Company’s standard Confidential Information and Invention Assignment Agreement, attached hereto as Appendix B; (ii) sign and return a
satisfactory I-9 Immigration form providing sufficient documentation establishing your employment eligibility in the United States, and (iii) provide satisfactory proof of your identity as required by United States law. Your duties under the
Confidential Information and Invention Assignment Agreement shall survive termination of your employment with the Company. By signing this letter, you acknowledge that a remedy at law for any breach or threatened breach by you of the provisions of
the Confidential Information and Invention Assignment Agreement would be inadequate, and you therefore agree that the Company shall be entitled to injunctive relief in case of any such breach or threatened breach. 

4. AT-WILL EMPLOYMENT. Your employment with the Company will be
“at-will,” meaning that either you or the Company will be entitled to terminate your employment at any time and for any or no reason, with or without cause. Although your job duties, title, compensation and benefits, as well as the
Company’s personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the Company. Your
participation in any stock purchase or benefit program is not to be regarded as assuring you continuing employment for any particular period of time. 
 5. OUTSIDE ACTIVITIES. While you render services to the Company, you will not engage in any other gainful employment, business or activity without the
written consent of the Company. While 

  
 2 

 
you render services to the Company, you also will not assist any person or organization in competing with the Company, in preparing to compete with the Company, or in hiring any employees of the
Company. During the term of your employment by the Company, except on behalf of the Company, you shall not directly or indirectly, whether as an officer, director, stockholder, partner, proprietor, associate, representative, consultant, or in any
capacity whatsoever engage in, become financially interested in, be employed by or have any business connection with any other person, corporation, firm, partnership or other entity whatsoever which were known by you to compete directly with the
Company, throughout the world, in any line of business engaged in (or planned to he engaged in) by the Company; provided, however, that anything above to the contrary notwithstanding, you may own, as a passive investor, securities of any competitor
corporation, so long as your direct holdings in any one such corporation shall not in the aggregate constitute more than 1% of the voting stock of such corporation. 
 6. SATISFACTORY REFERENCE CHECKS. This offer is contingent upon completion of professional reference checks by the Company, at its
discretion and to its satisfaction. 
 7. START DATE. Your start date shall
be on or before Monday, March 31, 2008. This offer, if not accepted, will expire at the close of business on Friday, March 7. 
 8. ENTIRE AGREEMENT. This offer letter sets forth the full and complete agreement between you and the Company regarding your employment with the
Company, Any additional or contrary terms, representations, offers or agreements, whether written or oral, that may have been made to you arc hereby revoked and superseded in their entirety by this offer. : 

We hope that you find the foregoing terms acceptable. You may indicate your agreement with these terms and accept this offer by signing
and dating both the enclosed duplicate original of this letter and the enclosed Confidential Information and Invention Assignment Agreement and returning them to me. 
 If you have any questions, please call Edward Ebbers at 925-474-2507. 
  

							
	 	 	 	 	Very truly yours,
				
	   /s/ Edward Ebbers
	 		 		 	   /s/ Mitchell Levinson

	  EDWARD EBBERS	 		 		 	  MITCHELL LEVINSON
	  VP OF MARKETING AND SALES	 		 		 	  PRESIDENT AND CEO

 AGREED AND ACCEPTED 
 I have read and accept this employment offer: 
  

			
	   /s/ David Heagy
	 	
	  David Heagy	 	
	   Date: 3/4, 2008
	 	

  
 3 

 Appendix A 

Draw Reconciliation Plan 

This Draw Reconciliation Plan applies to the first twelve (12) months following the Company’s commercial launch (the “Initial Commercial
Year”). During the Initial Commercial Year, the first $100,000 you earn in commissions pursuant to a commission plan approved by Company management will not be subject to Draw reconciliation. All commissions earned in excess of $100,000,
however, will be offset by the Draw you accrued prior to the Company’s commercial launch, in accordance with the following graduated schedule; 
  

									
	Incremental
Commission
Over $100K	 	Employee
Share	 	 	Offset to
Company	 
	$        10K	 	 	25	% 	 	 	75	% 
	$        10K	 	 	50	% 	 	 	50	% 
	$        10K	 	 	50	% 	 	 	50	% 
	$        10K	 	 	50	% 	 	 	50	% 
	$        10K	 	 	50	% 	 	 	50	% 
	$        10K	 	 	75	% 	 	 	25	% 
	$        10K	 	 	75	% 	 	 	25	% 
	$        10K	 	 	75	% 	 	 	25	% 
	$        10K	 	 	75	% 	 	 	25	% 
	$        10K	 	 	100	% 	 	 	0	% 

 Draw reconciliation will begin once your year-to-date commissions in the Initial Commercial Year exceed $100,000. For
example, and as illustrated by the schedule above, the first $10,000 in commissions earned in excess of $100,000 will be subject to the following split: 25% of it (i.e., $2,500) will go to you and 75% of it (i.e., $7,500) will go to
the Company in repayment of your Draw. Once you have earned $50,000 in commissions over $100,000, your commissions will be subject to the following split until the Draw is fully repaid or the Initial Commercial Year comes to an end, whichever is
sooner; 75% of the commissions will go to you and 25% of the commissions will go to the Company. 
 At the conclusion of the Initial Commercial
Year, if you have not earned any commissions in excess of $100,000, then the Company will forgive the entire Draw. Otherwise, the Company will forgive whatever amount of the Draw remains outstanding at the end of the Initial Commercial Year.

 Agreed and Accepted: 
  

	
	   /s/ Edward Ebbers

	  Edward Ebbers
	  VP of Marketing and Sales
	  Dated: March 3, 2008
	
	  /s/ David Heagy
	  David Heagy
	  Dated: March 4, 2008

  
 1 

 Appendix B 

Confidential Information and Invention Assignment Agreement 

As a condition of ray becoming employed (or my employment being continued) or retained as a consultant (or my consulting relationship
being continued) by Zeltiq Aesthetics, Inc., a Delaware corporation, with any of its current or future subsidiaries, affiliates, successors or assigns (collectively, the “Company”), and in consideration of my employment or
consulting relationship with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I agree to the following: 
 1. Employment or Consulting Relationship. I understand and acknowledge that this Agreement does not alter, amend or expand upon any rights I may have 1O continue in the employ of, or in a
consulting relationship with, or the duration of my employment OR consulting relationship with, the Company under any existing agreements between the Company and me or under applicable law. Any employment or consulting relationship between the
Company and me, whether commenced prior to or upon the date of this Agreement, shall be referred to herein as the “Relationship.” 
 2. At-Will Employment. I understand and acknowledge that my Relationship with the Company is and shall continue to be at-will, as defined under applicable law, meaning that cither I or the
Company may terminate the Relationship at any time for any reason or no reason, without further obligation or liability. 
 3.
Confidential Information. 
 (a) Company Information. I agree at all times during the term of my
Relationship with the Company and thereafter, to hold in strictest confidence, and not to use, except for the benefit of the Company, or to disclose to any person, firm, corporation or other entity without written authorization of the Board of
Directors of the Company, any Confidential Information of the Company which I obtain or create. I further agree not to make copies of such Confidential Information except as authorized by the Company. I understand that “Confidential
Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not limited to, research, product plans, products, services, suppliers, customer lists and customers (including, but not
limited to, customers of the Company on whom I called or with whom I became acquainted during the Relationship), prices and costs, markets, software, developments, inventions, laboratory notebooks, processes, formulas, technology, designs, drawings,
engineering, hardware configuration information, marketing, licenses, finances, budgets or other business information disclosed to me by the Company either directly or indirectly in writing, orally or by drawings or observation of parts or equipment
or created by me during the period of the Relationship, whether or not during working hours, and any information pertaining to any aspects of the Company’s business which is either information not known by actual or potential competitors of the
Company or is proprietary information of the Company or its customers or suppliers, whether of a technical nature or otherwise, I further understand that Confidential Information docs nut include any of the foregoing items which has become publicly
and widely known and made generally available through no wrongful act of mine or of others who were under confidentiality obligations as to the item or items involved. 

 (b) Former Employer Information. I represent that my performance of all terms
of this Agreement as an employee or consultant of the Company have not breached and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or trust prior or subsequent to the
commencement of my Relationship with the Company, and I will not disclose to the Company, or induce the Company to use, any inventions, confidential or proprietary information or material belonging to any previous employer or any other party.

 (c) Third Party Information. I recognize that the Company has received and in the future will receive from
third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes. I agree to hold all such confidential or
proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work for the Company consistent with the Company’s agreement with such third
party. 
 4. Inventions. 
 (a) Inventions Retained and Licensed. I have attached hereto, as Exhibit A, a list describing with particularity all inventions, original works of authorship, developments,
improvements, and trade secrets which were made by me prior to the commencement of the Relationship (collectively referred to as “Prior Inventions”), which belong solely to me or belong to me jointly with another, which relate in
any way to any of the Company’s proposed businesses, products or research and development, and which are not assigned to the Company hereunder; or, if no such list is attached, I represent that there are no such Prior Inventions. If, in the
course of my Relationship with the Company, I incorporate into a Company product, process or machine a Prior Invention owned by me or in which I have an interest, the Company is hereby granted and shall have a non-exclusive, royalty-free,
irrevocable, perpetual, worldwide license (with the right to sublicense) to make, have made, copy, modify, make derivative works of, use, sell and otherwise distribute such Prior Invention as part of or in connection with such product, process or
machine. 
 (b) Assignment of Inventions. I agree that I will promptly make full written disclosure to the
Company, will hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title and interest throughout the world in and to any and all inventions, original works of authorship,
developments, concepts, know-how, improvements or trade secrets, whether or not patentable or registrable under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed
or reduced to practice, during the period of time in which I am employed by or a consultant of the Company (collectively referred to as “Inventions”), except as provided in Section 4(e) below. I further acknowledge that all
inventions, original works of authorships developments, concepts, know-how, improvements or trade secrets which are made by me (solely or jointly with others) within the scope of and during the period of my Relationship with the Company are
“works made for hire” (to the greatest extent permitted by applicable law) and are compensated by my salary (if I am an employee) or by such amounts paid to me under any applicable consulting agreement or consulting arrangements (if
I am a consultant), unless regulated otherwise by the mandatory law of the state of California. 

 (c) Maintenance of Records. I agree to keep and maintain adequate and current
written records of all Inventions made by me (solely or jointly with others) during the term of my Relationship with the Company. The records may be in the form of notes, sketches, drawings, flow charts, electronic data or recordings, laboratory
notebooks, and any other format. The records will be available to and remain the sole property of the Company at all times. 1 agree not to remove such records from the Company’s place of business except as expressly permitted by Company policy
which may, from time to time, be revised at the sole election of the Company for the purpose of furthering the Company’s business. 
 (d) Patent and Copyright Rights. I agree to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions and
any copyrights, patents, trademarks, mask work rights, moral rights, or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto,
the execution of all applications, specifications, oaths, assignments, recordations, and all other instruments which the Company shall deem necessary in order to apply for, obtain, maintain and transfer such rights and in order to assign and convey
to the Company, its successors, assigns and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. I further agree
that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after the termination of this Agreement until the expiration of the last such intellectual property right to expire
in any country of the world. If the Company is unable because of my mental or physical incapacity or unavailability or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or
copyright registrations covering Inventions or original works of authorship assigned to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact,
to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance or transfer of letters patent or copyright registrations
thereon with the same legal force and effect as if originally executed by me. I hereby waive and irrevocably quitclaim to the Company any and all claims, of any nature whatsoever, which I now or hereafter have for infringement of any and all
proprietary rights assigned to the Company. 
 (e) Exception to Assignments. I understand that the provisions of
this Agreement requiring assignment of Inventions to the Company do not apply to any invention which qualifies fully under the provisions of California Labor Code Section 2870 (attached hereto as Exhibit B). I will advise the Company
promptly in writing of any inventions that 1 believe meet such provisions and are not otherwise disclosed on Exhibit A. 

5. Returning Company Documents. I agree that, at the time of termination of my Relationship with the Company, I will
deliver to the Company (and will not keep in my possession, recreate or deliver to anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, laboratory

 
notebooks, materials, flow charts, equipment, other documents or property, or reproductions of any aforementioned items developed by me pursuant to the Relationship or otherwise belonging to the
Company, its successors or assigns. I further agree that to any property situated on the Company’s premises and owned by the Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by
Company personnel at any time with or without notice. In the event of the termination of the Relationship, I agree to sign and deliver the “Termination Certification” attached hereto as Exhibit C. 

6. Notification to Other Parties. 
 (a) Employees. In the event that I leave the employ of the Company, I hereby consent to notification by the Company to my new employer about my rights and obligations under this Agreement,

 (b) Consultants. I hereby grant consent to notification by the Company to any other parties besides the Company
with whom I maintain a consulting relationship, including parties with whom such relationship commences after the effective date of this Agreement, about my rights and obligations under this Agreement. 

7. Solicitation of Employees, Consultants and Other Parties. I agree that during the term of ray Relationship with the
Company, and for a period of twelve (12) months immediately following the termination of my Relationship with the Company for any reason, whether with or without cause, I shall not either directly or indirectly solicit, induce, recruit or
encourage any of the Company’s employees or consultants to terminate their relationship with the Company, or take away such employees or consultants, or attempt to solicit, induce, recruit, encourage or take away employees or consultants of the
Company, either for myself or for any other person or entity. Further, for a period of twelve (12) months following termination of my Relationship with the Company for any reason, with or without cause, I shall not solicit any licensor to or
customer of the Company or licensee of the Company’s products, in each case, that are known to me, with respect to any business, products or services that are competitive to the products or services offered by the Company or under development
as of the date of termination of my Relationship with the Company. 
 8. Representations and Covenants.

 (a) Facilitation of Agreement. I agree to execute promptly any proper oath or verify any proper document
required to carry out the terms of this Agreement upon the Company’s written request to do so. 
 (b)
Conflicts. I represent that my performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to commencement of my Relationship
with the Company. I have not entered into, and I agree I will not enter into, any oral or written agreement in conflict with any of the provisions of this Agreement. 
 (c) Voluntary Execution. I certify and acknowledge that I have carefully read all of the provisions of this Agreement and that I understand and will fully and faithfully comply with such
provisions. 

 9. General Provisions. 

(a) Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the
laws of the State of California, without giving effect to the principles of conflict of laws. 
 (b) Entire
Agreement. This Agreement sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein and merges all prior discussions between us. No modification or amendment to this Agreement, nor any
waiver of any rights under this Agreement, will be effective unless in writing signed by the party to be charged. Any subsequent change or changes in my duties, obligations, rights or compensation will not affect the validity or scope of this
Agreement. 
 (c) Severability. If one or more of the provisions in this Agreement arc deemed void by law, then
the remaining provisions will continue in full force and effect. 
 (d) Successors and Assigns. This Agreement
will be binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 
 (e) Survival. The provisions of this Agreement shall survive the termination of the Relationship and the assignment of this Agreement by the Company to any successor in interest or other
assignee. 
 (f) ADVICE OF COUNSEL. I ACKNOWLEDGE THAT, IN EXECUTING THIS AGREEMENT, I HAVE HAD THE OPPORTUNITY TO
SEEK THE ADVICE OF INDEPENDENT LEGAL COUNSEL, AND I HAVE READ AND UNDERSTOOD ALL OF THE TERMS AND PROVISIONS OF THIS AGREEMENT. THIS AGREEMENT SHALL NOT BE CONSTRUED AGAINST ANY PARTY BY REASON OF THE DRAFTING OR PREPARATION HEREOF. 

[Signature Page Follows] 

 The parties have executed this Agreement on the respective dates set forth below:

  

									
	COMPANY:	 		 	EMPLOYEE:
			
	ZELTIQ AESTHETICS, INC.	 		 	DAVID HEAGY, an Individual:
			
	   /s/ Edward A. Ebbers
	 		 	   /s/ David Heagy

	  Signature	 		 	  Signature
		  		 		 	   David Heagy

	By:  Edward A. Ebbers	 		 	  Printed Name
				
	Title: VP, Marketing and Sales	 		 		 	
			
	Date:  3/3/08	 		 	Date:  3/4/08
	Address:	  	   4698 Willow Road

  Pleasanton, CA 94588
	 		 	 Address: 489 25th Street
 Hermosa Beach, CA 90254

 [ZELTIQ AESTHETICS LOGO] 
 April 12, 2010 
 Dear Dave, 
 It is my great pleasure to notify you of your promotion to Vice President NAF Sales, effective April 15, 2010. As VP, you will continue to report to me and will retain your current supervisory role
over our direct Sales organization. You have demonstrated to me and to the rest of the Senior Team that you are an incredibly productive, collaborative, and professional team player. Your development of the NAF organization thus far has been
impressive, and I trust that you will continue to drive them to great levels of achievement for the rest of 2010 and beyond. 
 As a result of
your promotion, your Base Salary will be increased to $175,000 per year. In addition, your Variable Compensation at target will be $110,000. The Variable Compensation will be paid monthly, based on the attainment of Revenue objectives and my
discretion. We will lock the balance of your Variable Compensation into the Q2-Q4 Forecast developed at our recent off-site. Finally, I am delighted to conditionally extend an offer of 250,000 shares of Stock Options (subject to Board/Compensation
Committee approval). If we deliver the business results that I believe are within our grasp, your stock options will provide a wonderful financial outcome for you and your family. 
 I’ve enjoyed our working relationship this far and look forward to this continuing. Congratulations on the promotion, Dave! 
 Sincerely, 
  

	
	/s/ Gordie
	
	Gordie Nye
	 President & Chief Executive Officer

 4698 Willow Road  Pleasanton, CA  94588 P  (888)-ZELTIQ-1  F (
925) 474-7599  www.zeltiq.comOffer Letter Agreement

 EXHIBIT 10.20 
 [ZELTIQ AESTHETICS LOGO] 
 April 29, 2010 

 
 Dear John: 
 Zeltiq Aesthetics, Inc. (the “Company”) is pleased to have you continue to serve as an employee of the Company in the position of Chief Financial Officer, reporting to the Company’s
President and Chief Executive Officer. This letter (this “Agreement”) sets forth the terms of your continued employment and amends and restates that certain offer letter agreement between you and the Company dated as of October 18,
2009 (the “Prior Agreement”) in its entirety. The terms of your continued employment are the following: 
  

	 	1.	Start Date: Your position as a full-time employee of the Company commenced on October 21, 2009. 

 

	 	2.	Salary: The Company will continue to pay you an annual salary of $230,000 to be paid monthly in accordance with the Company’s standard payroll policies
(subject to normal required withholding), and the Chief Executive Officer of the Company, as well as the Compensation Committee of the Board, will continue to review your salary level annually. 

 

	 	3.	Targeted Bonus: You will continue to be eligible to receive a discretionary annual bonus targeted for 25% of your annual salary upon meeting certain goals
mutually set by you and Chief Executive Officer of the Company within the first 60 days of your employment. Any bonus payable hereunder shall be paid prior to March 15 of the calendar year following the calendar year to which such bonus
relates. 

  

	 	4.	Existing Equity Grants: You have previously been granted options (“Initial Options”) to purchase an aggregate of 771,810 shares of Company common
stock, which represents 1.25% of the fully-diluted capitalization of the Company as of the date of this Agreement, which vest based upon your continued service to the Company with 25% of the shares subject to the Initial Options vesting on the first
anniversary of the commencement of your employment with the Company and l/48th of the total number of shares subject to the Initial Options vesting each month thereafter such that the Initial Options will be fully vested on the fourth anniversary of
the commencement of your employment with the Company. In the event that you choose to early exercise your Initial Options, the Company will have a right to repurchase any unvested shares at the lesser of cost or fair market value at the time of
repurchase in the event of termination of your employment relationship. Each option and any shares purchased upon exercise of such option will be subject to the terms of the Company’s current stock option plan or equity incentive plan and an
option agreement to be entered into between you and the Company. 

	 	5.	 Additional Equity Grants: Following the completion of each closing of the next preferred stock financing of the Company that results in net
proceeds to the Company of up to $25 million, you will be granted additional options (“New Options” and together with the Initial Options, “Options”) to purchase that number of shares of Company common stock necessary so that, as
of immediately following the applicable closing, the aggregate number of shares subject to your Options represents 1.25% of the fully-diluted capitalization of the Company. Your New Options will have a per share exercise price equal to the fair
market value of Company common stock on the date of grant, as determined by the Board, and shall vest based upon your continued service to the Company with 25% of the shares subject to the New Options vesting on the first anniversary of the
commencement of your employment with the Company and
l/48th of the total number of shares subject to the New
Options vesting each month thereafter such that the New Options will be fully vested on the fourth anniversary of the commencement of your employment with the Company. 

For the purposes of this Section 5, “fully diluted capitalization” includes all outstanding shares of capital stock plus
all shares subject to issuance under outstanding options or warrants plus all shares of capital stock reserved for future issuance under the Company’s stock option plan that are not subject to outstanding options or other equity awards. For the
avoidance of doubt, the dilution protection provided by this Section 5 shall only be in effect for the first $25 million of net proceeds to the Company from the next preferred stock financing of the Company. In the event the next preferred
stock financing of the Company results in net proceeds to the Company of more than $25 million, fully diluted capitalization shall be calculated based upon stock issued and stock option plan reserve increases in connection with the first $25 million
of net proceeds paid to the Company. 
 In the event that you choose to early exercise any options granted to you under this
Section 5, the Company will have a right to repurchase any unvested shares at the lesser of cost or fair market value at the time of repurchase in the event of termination of your employment relationship with the Company. Each option and any
shares purchased upon exercise of such option will be subject to the terms of the Company’s current stock option plan or equity incentive plan and an option agreement to be entered into between you and the Company. 

 

	 	6.	 Severance: In the event that your employment with the Company is terminated without Cause as defined in this Agreement, you will be entitled to
receive 6 months of base salary and COBRA (medical and dental insurance coverage), in each case, payable in substantially equal installments in accordance with the Company’s payroll practices, as severance, in exchange for you signing and not
revoking a severance agreement and general release against the Company and its affiliates within 60 days following your termination of employment (“Severance Agreement”). For purposes of this Agreement, Cause is defined as:
(i) willful failure by the Employee to substantially perform his duties hereunder, other than a failure resulting from the Employee’s complete or partial incapacity due to physical or mental illness or impairment, (ii) a willful act
by the Employee which constitutes gross misconduct and which is injurious to the Company, (iii) a willful breach by the Employee of a material provision of this Agreement, (iv) a material and willful violation of a federal or state law or
regulation applicable to the 

	 	
business of the Company, or (v) termination of your employment in connection with the bankruptcy, insolvency, liquidation, or similar winding-up of the business of the Company. No severance
benefits would be paid or provided to the Employee under this Agreement on account of a termination for Cause. 

  

	 	7.	Change in Control: During your employment with the Company, if a Change in Control of the Company occurs, and if you resign for Good Reason or are terminated
without Cause within one year following such Change in Control, then you will receive immediate vesting of any outstanding stock options or other equity awards. 

 “Good Reason” shall mean solely and specifically: (i) any material reduction in your base salary or any guaranteed bonus, (ii) a material diminution of your job duties or
responsibilities, or (iii) a change in the location of your employment of more than 20 miles (which is material) from its current location unless such relocation is within 50 miles of your principal residence. 

For purposes of this Agreement, “Change in Control” means (a) a sale of all or substantially all of the Company’s
assets, or (b) any merger, consolidation or other business combination transaction of the Company with or into another corporation, entity or person, other than a transaction in which the holders of at least a majority of the shares of voting
capital stock of the Company outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding or by their being converted into shares of voting capital stock of the surviving entity) a majority of the
total voting power represented by the shares of voting capital stock of the Company (or the surviving entity) outstanding immediately after such transaction other than any transaction involving the issuance of any newly issued equity securities
solely for cash. 
  

	 	8.	Notice and Opportunity to Cure: Notwithstanding the foregoing, in order to terminate your employment for Good Reason (i) you shall first give the Company
written notice stating with reasonable specificity the basis for the termination with Good Reason within ninety (90) days of the first occurrence of the event giving rise to Good Reason, (ii) give the Company a period of thirty
(30) days to cure or remedy the problem, unless such problem cannot be cured or remedied within thirty (30) days, in which case the period for remedy or cure shall be extended for a reasonable time (not to exceed an additional thirty
(30) days) and (iii) terminate your employment within thirty (30) days following the expiration of such cure period. 

  

	 	9.	Benefits: You shall be entitled the Company’s basic employment benefits available to all Company Employees. Specifically, the Zeltiq Human Resources
Department will work with you to ensure adequate healthcare insurance coverage for you and your family. Details of the Company’s benefits will sent to you under separate cover. 

 

	 	10.	 At-Will Employment. Your employment with the Company will be “at-will,” meaning that either you or the Company will be entitled to
terminate your employment at any time and for any or no reason, with or without cause. Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the
“at will” nature of your employment may only be 

	 	
changed in an express written agreement signed by you and a duly authorized officer of the Company. Your participation in any stock purchase or benefit program is not to be regarded as assuring
you continuing employment for any particular period of time. 

  

	 	11.	Agreements: You previously signed the Company’s standard Employee Agreement. You agree to abide by such Employee Agreement and by the Company’s policy
that prohibits any new employee from bringing with him or her from any previous employer any confidential information, trade secrets, or proprietary materials or processes of such former employer. You will agree to follow the Company’s policy
that employees must not disclose any information regarding salary, bonuses, or stock purchase or option allocations to other employees, either directly or indirectly. 

 

	 	12.	Section 409A: Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement that constitutes
“nonqualified deferred compensation” (“Deferred Compensation”) within the meaning of Section 409 A of the Internal Revenue Code of 1986, as amended (the “Code”), and which is designated under this Agreement as
payable upon your termination of employment shall be payable only upon your “separation from service” with the Company within the meaning of Section 409 A of the Code (a “Separation from Service”) and, except as otherwise
provided under this paragraph, any such compensation or benefits shall not be paid, or, in the case of installments, shall not commence payment, until the sixtieth (60th) day following your Separation from Service. Any installment payments that
would have been made to you during the sixty (60) day period immediately following your Separation from Service but for the preceding sentence shall be paid to you on the sixtieth (60th) day following your Separation from Service and the
remaining payments shall be made as provided in this Agreement. Notwithstanding any provision herein to the contrary, if you are deemed by the Company at the time of your Separation from Service to be a “specified employee” for purposes of
Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which you are entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i)
of the Code, such portion of your benefits shall not be provided to you prior to the earlier of(i) the expiration of the six-month period measured from the date of your Separation from Service with the Company or (ii) the date of your death.
Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to you (or your estate or beneficiaries), and any
remaining payments due to you under this Agreement shall be paid as otherwise provided herein. To the extent that any reimbursements under this Agreement are subject to the provisions of Section 409A of the Code, any such reimbursements payable
to you shall be paid to you no later than December 31 of the year following the year in which the expense was incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year,
and your right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit. Your right to receive any installment payments under this Agreement, including without limitation any continuation salary
payments that are payable on Company payroll dates, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted
under Treasury Regulation Section 1.409A-2(b)(2)(iii). 

	 	13.	Entire Agreement: This Agreement, together with your Employee Agreement, constitutes the entire agreement between the parties with respect to your employment
with the Company, superseding all other agreements or understanding, including, without limitation, the Prior Agreement. 

 John,
we are delighted to have you continue with our team. We’ve got a lot to accomplish, and I’m confident that you’ll continue to prove to be a major contributor to a successful outcome at Zeltiq. 

Sincerely, 
 /s/ Gordie Nye 

Gordie Nye 
 President & CEO 

Accepted and Agreed: 
  

	
	   /s/ John Howe

	  John Howe

 Date: 4/29/10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]